Gemma L Saravanos
Overview
Explore the profile of Gemma L Saravanos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burrell R, Saravanos G, Kesson A, Leung K, Outhred A, Wood N, et al.
PLoS One
. 2025 Jan;
20(1):e0313504.
PMID: 39841690
Acute respiratory infections cause significant paediatric morbidity, but for pathogens other than influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, systematic monitoring is not commonly performed. This retrospective analysis of six...
2.
Saravanos G, Islam M, Huang Y, Basseal J, Seale H, Mitchell B, et al.
BMC Glob Public Health
. 2024 Dec;
2(1):6.
PMID: 39681863
No abstract available.
3.
Ozturk A, Chan M, Khan J, Hu N, McMullan B, Britton P, et al.
J Infect Dis
. 2024 Nov;
PMID: 39484989
Background: Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections (ALRIs) associated hospitalisations in children. It is unclear if hospitalized RSV-ALRI differs in clinically from other...
4.
Tyagi V, Saravanos G, Dunsmore M, Power T, McCormack B
J Adv Nurs
. 2024 Mar;
81(1):537-540.
PMID: 38491563
No abstract available.
5.
Lim S, Chan M, Hu N, McMullan B, Britton P, Bartlett A, et al.
Pediatr Infect Dis J
. 2024 Feb;
43(6):511-517.
PMID: 38377461
Background: Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections (ALRIs) in children <2 years of age. Currently, there are limited data on risk factors for...
6.
Stiboy E, Chan M, Islam M, Saravanos G, Lui K, Jaffe A, et al.
Pediatr Pulmonol
. 2023 Feb;
58(4):1210-1220.
PMID: 36748923
Background: Uniformity and compliance with clinical practice guidelines (CPGs) for use of palivizumab in preventing severe respiratory syncytial viral infection in Australian high-risk infants remain unclear. Methods: An online survey...
7.
Williams P, Koirala A, Saravanos G, Lopez L, Glover C, Sharma K, et al.
Med J Aust
. 2022 Jul;
217(6):303-310.
PMID: 35851698
Objectives: To describe the severity and clinical spectrum of coronavirus disease 2019 (COVID-19) in children during the 2021 New South Wales outbreak of the Delta variant of the severe acute...
8.
Saravanos G, Hu N, Homaira N, Muscatello D, Jaffe A, Bartlett A, et al.
Pediatrics
. 2022 Jan;
149(2).
PMID: 35083489
COVID-19 public health measures altered respiratory syncytial virus (RSV) epidemiology. We examined age-stratified trends in RSV-related disease in Australian children in 2020 compared with previous years.
9.
Saravanos G, Hsu P, Isaacs D, Macartney K, Wood N, Britton P
Pediatr Infect Dis J
. 2021 Nov;
41(3):186-191.
PMID: 34845151
Background: Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection and an important contributor to child mortality. In this study, we estimated the frequency and...
10.
Saravanos G, King C, Deng L, Dinsmore N, Ramos I, Takashima M, et al.
J Pediatr
. 2021 Jun;
239:39-49.e9.
PMID: 34181989
Objectives: To describe the features and frequency of respiratory syncytial virus (RSV)-associated severe acute neurologic disease in children. Study Design: We performed a systematic review of the literature to identify...